L14. Pharmacological aspects of immunology (Theme 1) Flashcards
examples of NSAIDS
Large, chemically diverse family of drugs:
Aspirin
Paracetamol
Propionic acid derivatives - e.g. ibuprofen, naproxen
Arylalkanoic acids – e. g indometacin, diclofenac
Oxicams - e.g. piroxicam
Fenamic acids - e.g. mefanamic acid
Butazones - e.g. phenylbutazone
Coxibs e.g. celecoxib
what is the Eicosanoid pathway
Study slide 6
what do nSAIDS all do
They antagonise cyclooxygenase stopping the conversion of arachidonics and Prostaglandins H2 to thromboxanes
what are the 3 isoforms of cyclo-oxygenases
COX-1 - Constitutive expression
COX-2 – Induced in inflammation
COX-3 – CNS only?
what are the indications for NSAID therapy
Short-term management of pain (and fever):
As mild analgesics (orally and topically)
- mechanical pain of all types
- minor trauma
- headaches, dental pain
- dysmenorrhoea
As potent analgesics (orally, parenterally, rectally)
- peri-operative pain
- ureteric colic
what are NSAID used for
for gout
inflammatory arthritis e.g- ankylosing spondylitis, rheumatoid arthritis
what is Aspirin used for
Use for pain and inflammation limited by
- GI toxicity
- Tinnitus – mechanism obscure, usually reversible
- Reye’s syndrome (fulminant hepatic failure in children)
Anti-platelet effect
Prophylaxis of -ischaemic heart disease
-Treatment of acute MI
Clopidogrel and dipyrimidole
-Non-NSAID antiplatelet drugs
action of paracetamol/acetaminophen
Doesn’t bind COX1 or 2.
No significant anti-inflammatory action
No significant GI toxicity
Analgesic/ anti-pyretic
Dangerous in overdose (see later slides)
how is paracetamol metabolised
see slide 17
describe NSAID GI toxicity
In the GI tract prostaglandins E2 and I2
- Decrease acid production
- Increase mucus production
- Increase blood supply
NSAID inhibition in stomach and duodenum
- Irritation
- Ulcers (gastric 15-30%, duodenal 10%)
- Bleeding
Similar effect in the colon
-Colitis – esp with local preps e.g. rectal diclofenac
describe NSAID nephrotoxicity
Primarily related to changes in glomerular blood flow:
- Decreased glomerular filtration rate
- Sodium retention
- Hyperkalaemia
- Papillary necrosis
Acute renal failure 0.5-1%
Avoid or dose adjust in renal failure
Avoid in patients likely to develop renal failure
study slide
21
describe NSAIDs in increasing toxicity
Ibuprofen- naproxen- dielofenae - indomethacin
how can you prevent NSAID toxicity
Is an NSAID the answer (paracetamol, opioids?)
In terms of GI toxicity
Treatment with
Gastroprotective drugs (misoprostil – PGE1 analogue, or proton pump inhibitor)
Avoid in renal failure, dose adjust if necessary
describe selective COX-2 inhibitors
Selective inhibition of COX-2 in vitro and in vivo
Anti-inflammatory and analgesic in humans
Objective evidence of selectivity (GI, platelets) at > anti-inflammatory doses
The ‘coxibs’:
- celecoxib
- etoricoxib
- rofecoxib
- valdecoxib